None listed
Conditions
Interventions
Experimental group:Intravenous fentanyl 10µg/kg
Control group 1:Intravenous butorphanol 20µg/kg
Control group 2:Intravenous sufentanil 0.1ug/kg
Sponsors
Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1. Women who intend to undergo hysteroscopic surgery; 2. Aged 18-55 years; 3. American Society of Anesthesiologists (ASA) grade I to II.
Exclusion criteria
Exclusion criteria: 1. Patients who refused to participate in the trial; 2. Patients with a history of serious heart, brain, lung, liver, kidney and metabolic diseases; 3. Patients with a history of recovery from abnormal surgical anesthesia; 4. Electrocardiogram: heart rate 180mmHg and/or diastolic blood pressure >110mmHg in hypertensive patients, or <90/60mmHg in hypotensive patients; 7. Patients with neuromuscular system diseases and mental diseases; 8. Anemia patients; 9. Suspected abuse of narcotic analgesics or sedatives; 10. Those who predict that difficult airway may occur or have occurred before; 11. Known allergy to emulsions and opiates; 12. Uncooperative and unable to communicate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body movement response times;Propofol total dosage;Time to reach a score of 5 on the modified Vigilance/Sedation Scale (MOAA/S);Pulse oxygen saturation in PACU; | — |
Countries
China
Contacts
Public ContactYuan Hongmei
Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital
Outcome results
None listed